Alan M. Zuckerman
The Problem
Community Health and University Health are two healthcare organizations in a state that has recently seen the continued growth and rising market power of a large health system, as well as physician and insurer changes and challenges. Both organizations have been financially healthy, but downturns in the past three months suggest that the good times may be at an end.
The Situation
Like many other markets, the state in this scenario has experienced widespread consolidation of providers over the past 10 years. One system, in particular, based in the largest metropolitan area in the state, has been especially aggressive in functioning as a consolidator. This system has captured a 45 percent share of the metro market (population of 1.5 million), is a significant presence throughout the southern and most populous half of the state, and now has about 15 percent to 20 percent of that market, too.
The provider landscape has changed dramatically in this metropolitan area. As a result of closures and consolidations, only one independent hospital (Children’s) remains where there had previously been 20. In addition to the large system (which comprises five hospitals), the four other players, all of which operate essentially exclusively in the metro area, are:
- Community Health with three hospitals and a 13 percent share
- University Health with two hospitals and a 12 percent share
- Catholic Health with four hospitals and a 17 percent share
- North Suburban Health with two hospitals and an 8 percent share
The physician market is also consolidating. Each system has a large employed group that is roughly in proportion to its size and mostly, but not exclusively, primary-care-based. The only exceptions are University Health and Children’s, where physician groups are dominated by specialty-oriented faculty practice plans. There are still a few large independent multispecialty groups and many single-specialty groups, but here, too, these groups are increasingly migrating to a relationship (employment or tight joint venture) with one of the systems.
The insurance market has been relatively benign until the past few years. The commercial insurers’ favored product has been the preferred provider organization (PPO). But here, as well, the market is changing. Three years ago, there were six commercial insurers, and not one had more than a 25 percent share of the market. Since then, the two smallest have merged, and two of the remaining four have been bought by national companies. As a result, the competitive ante has been raised and providers have begun to be squeezed; and the competitive pressures are expected to become much more intense in the next two to three years.
In this environment, six months ago, the CEOs of University Health and Community Health began discussing a potential relationship. Concerned about the increasing market power of the large system and the developments involving physicians and insurers, both CEOs thought the time may be right to merge their organizations.
Alternatives Considered and Analysis
Initially, the two CEOs discussed a range of organizational affiliation options, from a shared services company to full merger. But they quickly realized that a tight relationship would be required to achieve the cost savings and managed care contracting benefits they wanted. So they charged financial staff and consultants early on to define financial benefits in four categories (see exhibit):
- Low-risk, relatively easy-to-implement cost-reduction opportunities
- High-risk, relatively difficult-to-implement cost-reduction opportunities
- Capital cost avoidance opportunities
- Revenue improvement opportunities
Because both systems are themselves the product of previous mergers and had six and nine years of experience, respectively, functioning as merged entities, there was some skepticism as to the potential for significant additional economies. However, these two systems largely operate in different parts of the metro area, so combining could improve geographic coverage while avoiding conflict between the two organizations (for the most part) over the same markets.
Although the numbers may look large in absolute terms, the combined entity has annual revenue of $1.3 billion. And the two CEOs recognized that achievement of the financial benefits estimated would not be without extremely hard work and major organizational change and pain. So the question for the CEOs and the joint board oversight committee that received this analysis is: Does the gain justify the pain?
The Decision
The two CEOs were truly divided about whether the benefits were great enough to proceed. The time frame for reaching a decision was extended twice while the leaders debated together and separately about the feasibility and desirability of moving forward with the relationship. Not surprisingly, the CFOs and their staffs were asked to perform additional analyses, validate and refine the projections provided, and perform sensitivity analyses. None of the findings of these analyses materially affected the initial results summarized in the exhibit below.
As the two organizations saw their financial performance eroding, they concluded that it made sense to proceed with the merger. The joint board oversight committee charged the CEOs and CFOs with developing a detailed implementation plan for achieving the projected financial benefits that would also describe the steps required to realize another $20 million to $40 million of margin improvement and $25 million to $50 million of capital cost avoidance by year three.
Alan M. Zuckerman, FACHE, FAAHC, is president, Health Strategies & Solutions, Inc., Philadelphia (azuckerman@hss-inc.com).
FY08 Profile: University Health
Acute beds: 650
Inpatient admissions: 35,000
Outpatient visits: 550,000
FTE employees: 4,500
Net patient revenue: $750 million
Operating margin: 8.0%
Unrestricted cash: $500 million
Debt to capitalization: 29.4%
Age of plant (years): 6.4
FY08 Profile: Community Health
Acute beds: 500
Inpatient admissions: 26,000
Outpatient visits: 850,000
FTE employees: 4,200
Net patient revenue: $575 million
Operating margin: 7.5%
Unrestricted cash: $200 million
Debt to capitalization: 29.0%
Age of plant (years): 10.5